Time
Days to earnings16
Next print2026-11-03
WindowBMO
Fiscal2026-09-30
NYSE · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
PFE
Pfizer Inc primary
28.42
Full stocks workspace →+0.14+0.5%
Street
Consensus EPS0.759
Consensus revenue15.9B
EPS high / low0.94 / 0.59 · 46.1% · n=18
Rev / avg0 / — · 0.759 / 0.759
Options
IV front21.0%
Implied move5.2%
Put/call full0.78
Put/call front0.40
Short interest
Short shares150.2M / 155.2M · -3.21%
Days to cover4.41
Avg vol · float34.0M · 5.7B
Short % float2.64%
| Date | DTE | Next | Close | Cons. EPS | IV front % | Implied | Ret 5d | Ret 10d | Ret 20d | Ret 30d | EPS high / low | Dispersion | Analysts | P/C | Peers rpt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-12 | 16 | 2026-11-03 | 28.42 | 0.759 | 21.0% | 5.2% | +3.7% | -1.1% | +2.5% | +1.6% | 0.94 / 0.59 | 46.1% | 18 | 0.78 | 0 | |
| 2026-10-09 | 17 | 2026-11-03 | 28.27 | 0.759 | 23.0% | 6.0% | +1.7% | -1.4% | +2.0% | +0.9% | 0.94 / 0.59 | 46.1% | 18 | 0.78 | 0 | |
| 2026-10-08 | 18 | 2026-11-03 | 27.83 | 0.759 | 22.5% | 6.0% | -1.0% | -2.0% | +0.7% | -1.7% | 0.94 / 0.59 | 46.1% | 18 | 0.80 | 0 | |
| 2026-10-07 | 19 | 2026-11-03 | 27.99 | 0.759 | 21.0% | 5.7% | -1.9% | -0.7% | +0.8% | -2.0% | 0.94 / 0.59 | 46.1% | 18 | 0.80 | 0 | |
| 2026-10-06 | 20 | 2026-11-03 | 27.49 | 0.759 | 22.5% | 6.2% | -4.3% | -1.6% | -1.1% | -1.7% | 0.94 / 0.59 | 46.1% | 18 | 0.80 | 0 | |
| 2026-10-05 | 21 | 2026-11-03 | 27.41 | 0.759 | 21.5% | 6.1% | -4.6% | -1.2% | -3.7% | -2.4% | 0.94 / 0.59 | 46.1% | 18 | 0.75 | 0 | |
| 2026-10-02 | 22 | 2026-11-03 | 27.80 | 0.759 | 21.5% | 6.4% | -3.1% | +0.5% | -3.5% | +0.0% | 0.94 / 0.59 | 46.1% | 18 | 0.75 | 0 | |
| 2026-10-01 | 23 | 2026-11-03 | 28.12 | 0.759 | 23.0% | 6.9% | -1.0% | +1.7% | -3.1% | -0.4% | 0.94 / 0.59 | 46.1% | 18 | 0.75 | 0 | |
| 2026-09-30 | 24 | 2026-11-03 | 28.53 | 0.759 | 22.0% | 6.7% | +1.2% | +3.9% | -0.1% | +4.7% | 0.94 / 0.59 | 46.1% | 18 | 0.75 | 0 | |
| 2026-09-29 | 25 | 2026-11-03 | 28.73 | 0.759 | 22.0% | 6.8% | +2.8% | +4.3% | +0.9% | +6.9% | 0.94 / 0.59 | 46.1% | 18 | 0.75 | 0 |
Linked names and their last print
| Peer | Name | Score | Last qtr | Last surprise | Reaction | 1-day close | DTE (full) |
|---|---|---|---|---|---|---|---|
| BMY primary | Bristol-Myers Squibb Company | 0.59 | 2026Q2 · 2026-07-30 | +28.3% | -0.6% | 64.86 | 13 · 2026-10-12 |
| MRK primary | Merck & Company Inc | 0.53 | 2026Q2 · 2026-08-04 | +50.0% | +0.5% | 128.00 | 13 · 2026-10-12 |
| ABBV primary | AbbVie Inc | 0.41 | 2026Q2 · 2026-07-31 | +0.3% | -1.9% | 250.94 | 14 · 2026-10-12 |
| JNJ primary | Johnson & Johnson | 0.30 | 2026Q2 · 2026-07-15 | +2.1% | -1.5% | 247.02 | 1 · 2026-10-12 |
| Fiscal qtr | Report date | Window | Actual EPS | Surprise % | Beat | Reaction | 1-day result | Vol ×10d | Post 10d | Review |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2026-08-04 | BMO | 0.77 | +13.2% | Beat | +0.0% | +1.5% | 1.68× | +7.2% | Review |
| 2026Q1 | 2026-05-05 | BMO | 0.75 | +4.2% | Beat | +1.1% | -0.5% | 1.55× | -3.0% | Review |
| 2025Q4 | 2026-02-03 | BMO | 0.66 | +15.8% | Beat | -4.9% | +1.6% | 1.82× | +6.2% | Review |
| 2025Q3 | 2025-11-04 | BMO | 0.87 | +38.1% | Beat | -1.1% | -0.4% | 2.27× | +4.7% | Review |
| 2025Q2 | 2025-08-05 | BMO | 0.78 | +36.8% | Beat | +3.1% | +2.0% | 2.66× | +2.3% | Review |
| 2025Q1 | 2025-04-29 | BMO | 0.92 | +37.3% | Beat | -1.0% | +4.2% | 2.18× | -3.9% | Review |
| 2024Q4 | 2025-02-04 | BMO | 0.63 | +37.0% | Beat | -0.4% | -0.9% | 1.72× | +0.1% | Review |
| 2024Q3 | 2024-10-29 | BMO | 1.06 | +73.8% | Beat | +0.5% | -1.9% | 3.71× | -8.0% | Review |
| 2024Q2 | 2024-07-30 | BMO | 0.60 | +30.4% | Beat | +0.9% | +1.2% | 2.42× | -8.1% | Review |
| 2024Q1 | 2024-05-01 | BMO | 0.82 | +60.8% | Beat | +2.8% | +3.2% | 2.59× | +6.0% | Review |